NorthRock Partners, LLC
- SEC CIK
- 0001632097
- Latest filing
- Aug 11, 2026
DFTX holding history
Definium Therapeutics, Inc. in every 13F filed by NorthRock Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DFTX overviewAll 13F holders of DFTXFull Q2 2026 holdings
- Shares (Q3 2022)
- 0
- Sold out in Q3 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | 0.0% | −713−100.0% | Sold outConverted for a 1-for-15 split | Holders |
| Q2 2022 | 10,702 | $7.00K | <0.1% | −48−0.4% | Reduced | Holders |
| Q1 2022 | 10,750 | $12.0K | <0.1% | −31−0.3% | Reduced | Holders |
| Q4 2021 | 10,781 | $15.0K | <0.1% | +426+4.1% | Added | Holders |
| Q3 2021 | 10,355 | $25.0K | <0.1% | −300−2.8% | Reduced | Holders |
| Q2 2021 | 10,655 | $37.0K | <0.1% | +10,655 | New | Holders |